Exelixis EVP sells 47,918 shares at $44.50

Exelixis EVP of Research and Development Dana Aftab reported an open-market sale of 47,918 shares of common stock at $44.50 per share.

Rhea-AI Filing Summary

Exelixis EVP of Research and Development Dana Aftab reported an open-market sale of 47,918 shares of common stock at $44.50 per share. After this sale, Aftab directly holds 616,106 shares, which include 414,043 shares tied to unvested RSUs and PSUs.

Aftab also indirectly holds 5,835 shares through the Exelixis 401(k) plan, based on a statement dated February 23, 2026.

Insider Trade Summary

Net Seller: 47,918 shares

Net Sell 2 txns

Insider Aftab Dana

Role EVP, Research and Development

Sold 47,918 shs ($2.13M)

Type	Security	Shares	Price	Value
Sale	Common Stock	47,918	$44.50	$2.13M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 616,106 shares (Direct); Common Stock — 5,835 shares (Indirect, By 401(k))

Footnotes (2)

1. F1. Includes 414,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
2. F2. Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 23, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did EXEL EVP Dana Aftab report?

Dana Aftab reported an open-market sale of Exelixis shares. The Form 4 shows a sale of 47,918 shares of common stock at $44.50 per share, executed as an open-market or private transaction on February 24, 2026.

How many EXEL shares did Dana Aftab sell and at what price?

Dana Aftab sold 47,918 Exelixis common shares at $44.50 each. This sale was reported as an open-market or private transaction and represents a net-sell direction of 47,918 shares in the latest Form 4 filing.

How many EXEL shares does Dana Aftab own after the reported sale?

After the sale, Dana Aftab directly owns 616,106 Exelixis shares. This total includes 414,043 shares that will be issued upon vesting of RSUs and PSUs. Aftab also indirectly holds 5,835 shares through the company’s 401(k) plan.

What equity awards are included in Dana Aftab’s EXEL holdings?

Aftab’s holdings include 414,043 shares linked to RSUs and PSUs. These awards, granted on March 31, 2025, will convert into Exelixis common stock upon vesting, with each unit representing the economic equivalent of one share.

How many EXEL shares does Dana Aftab hold through the 401(k) plan?

Dana Aftab indirectly holds 5,835 Exelixis shares via the 401(k) plan. This figure comes from a plan statement dated February 23, 2026, and is reported as indirect ownership separate from Aftab’s directly held and award-related shares.

Does the Form 4 for EXEL show any insider share purchases?

The Form 4 does not report any insider purchases by Dana Aftab. It records one open-market sale totaling 47,918 shares and one additional entry reflecting indirect 401(k) holdings, with the overall activity classified as net selling.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 06:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aftab Dana

(Last) (First) (Middle)

C/O EXELIXIS, INC.

1851 HARBOR BAY PARKWAY

(Street)

ALAMEDA CA 94502

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Research and Development

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		S		47,918	D	$44.5	616,106(1)	D
Common Stock								5,835(2)	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 414,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

2. Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 23, 2026.

Remarks:

	/s/ Nina Ayer, Attorney in Fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.